Skip to main content
See every side of every news story
Published loading...Updated

Mounjaro Maker Eli Lilly Jumps In Quality Despite Trump-Fueled Price Cut Fears - Eli Lilly (NYSE:LLY)

Summary by Benzinga
Eli Lilly and Co. (NYSE:LLY) has surged into the top decile of quality rankings among S&P 500 peers, achieving a percentile score of 90.25 on the latest composite quality report, despite fresh uncertainty surrounding the future pricing of its blockbuster weight loss drug, Mounjaro. Check out LLY stock price here. Trump Drug Price Reduction Threat Keeps LLY Quality Unfazed The pharmaceutical giant's climb in operational and financial quality arri…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Friday, October 24, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal